Arrhythmias & electrophysiology
Patient Centered mobile Health TECHnology Enabled Atrial Fibrillation Management (mTECH Afib)): A Pilot Randomized Controlled Trial
Authors' conclusion
The mTECH Afib (Patient Centered mobile health TECHnology Enabled Atrial Fibrillation Management) trial demonstrates feasibility of conducting a randomized controlled trial using an innovative digital health technology-enabled intervention with broad patient engagement and acceptance of the program components. Large-scale clinical trials powered for health outcomes will be necessary to establish intervention efficacy.
Study context
- Population
- Patients with atrial fibrillation (AF) enrolled from outpatient clinics76% of those approached
- Participants
- 61 patients
- Comparison
- Virtual program vs usual care only
Methodological detailsfeasibility, 1:1 randomization
- Feasibility
- 1:1 randomization
Primary result
As reported in the abstract
Participant retention · 12-week follow-up
Retained, all participants
89%
Further findings
Intervention engagement and satisfaction (intervention group) · 12 weeks
- Continued using the smartphone application
- 88%
- Continued participation in virtual coaching calls
- 73%
- Reported being satisfied with the program
- 80%
Baseline characteristics
- Mean age
- 65 ± 8 years
- Women
- 36%
Original publication
Patient Centered mobile Health TECHnology Enabled Atrial Fibrillation Management (mTECH Afib)): A Pilot Randomized Controlled Trial. JACC Clin Electrophysiol. Published 30 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →